Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A 3-year structured exercise program post-chemotherapy improved disease-free and overall survival in stage III or high-risk stage II colon cancer patients. Patients in the exercise program reported ...

A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

When treatment for colon cancer ends, many patients are left with a simple but pressing question: “What else can I do to keep the cancer from coming back?” Thanks to a landmark clinical trial ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...